Hot Features
Premium
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Zeitraum:
Zeichenmodus:
| Volumen | 7.265 |
|
|||||
| News | - | ||||||
| Tageshoch | 3,13 | Niedrig Hoch |
|||||
| Tagestief | 2,833 | ||||||
| Name | Symbol | Markt | Aktientyp |
|---|---|---|---|
| Anebulo Pharmaceuticals Inc | ANEB | NASDAQ | Common Stock |
| Änderung | Änderung % | Aktuell | Zeit
|
|
|---|---|---|---|---|
| 0,01 | 0,33% | 3,01 | 18:38:00 |
| Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
|---|---|---|---|---|
| 3,13 | 2,833 | 3,13 | 3,00 |
| Trades | Volumen | VWAP | Finanzielles Volumen | Durchsch. Volumen | 52 Week Range |
|---|---|---|---|---|---|
| 86 | 7.265 | US$ 3,06 | US$ 22.241 | - | 1,62 - 4,05 |
| Letzte Trade | Typ | Menge | Kurs | Währung |
|---|---|---|---|---|
| 18:21:54 | 1 | US$ 3,00 | USD |
Finanzwerte ANEB
| Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
|---|---|---|---|---|---|---|
| 78,06M | 25,93M | - | 0 | -11,73M | -0,45 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Anebulo Pharmaceuticals
| Datum | Zeit | Quelle | Überschrift |
|---|---|---|---|
| 13.2.2024 | 22:30 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 13.2.2024 | 22:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 13.2.2024 | 22:05 | Business Wire | Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year.. |
| 21.11.2023 | 22:01 | Edgar (US Regulatory) | Form 8-K - Current report |
| 14.11.2023 | 22:05 | Business Wire | Anebulo Pharmaceuticals Reports First Quarter Fiscal Year.. |
| 30.10.2023 | 14:31 | Edgar (US Regulatory) | Form ARS - Annual Report to Security Holders |
| 30.10.2023 | 14:22 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
| 19.10.2023 | 23:18 | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements |
| 06.10.2023 | 22:10 | Edgar (US Regulatory) | Form 8-K - Current report |
| 06.10.2023 | 22:06 | Business Wire | Anebulo Pharmaceuticals Announces New CEO |
| 02.10.2023 | 23:01 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of.. |
| 22.9.2023 | 22:05 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
Forum Anebulo Pharmaceuticals
Keine Diskussionen Gefunden.Neuen Thread Erstellen
ANEB Historisch
| Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
|---|---|---|---|---|---|---|---|
| 1 Woche | 3,19 | 3,19 | 2,79 | 2,98 | 1.833 | -0,18 | -5,64% |
| 1 Monat | 2,99 | 3,30 | 2,61 | 2,91 | 3.628 | 0,02 | 0,67% |
| 3 Monate | 2,66 | 3,30 | 2,40 | 2,78 | 5.482 | 0,35 | 13,16% |
| 6 Monate | 2,15 | 3,30 | 1,87 | 2,40 | 10.204 | 0,86 | 40,00% |
| 1 Jahr | 2,48 | 4,05 | 1,62 | 2,50 | 9.542 | 0,53 | 21,37% |
| 3 Jahre | 7,00 | 9,33 | 1,62 | 4,34 | 9.400 | -3,99 | -57,00% |
| 5 Jahre | 7,38 | 9,33 | 1,62 | 4,61 | 10.399 | -4,37 | -59,21% |
